Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study

Simple item page
dc.contributor.authorEmek Kocatürk
dc.contributor.authorPascale Salameh
dc.contributor.authorEsra Saraç
dc.contributor.authorCarolina Elisa Vera Ayala
dc.contributor.authorSimon Francis Thomsen
dc.contributor.authorTorsten Zuberbier
dc.contributor.authorLuís Felipe Ensina
dc.contributor.authorTodor A. Popov
dc.contributor.authorMartijn B. A. van Doorn
dc.contributor.authorAna M. Giménez‐Arnau
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:17:02Z
dc.date.available2026-03-22T14:17:02Z
dc.date.issued2023
dc.descriptionCitaciones: 19
dc.identifier.doi10.1016/j.jaci.2023.07.019
dc.identifier.urihttps://doi.org/10.1016/j.jaci.2023.07.019
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45609
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofJournal of Allergy and Clinical Immunology
dc.sourceKoç University
dc.subjectMedicine
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectChronic urticaria
dc.subjectVaccination
dc.subject2019-20 coronavirus outbreak
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.subjectAdverse effect
dc.subjectDermatology
dc.titleUrticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
dc.typearticle

Files

Collections

Artículo Científico Publicado